Answer
Palopegteriparatide has a predicted half-life of 70 hours in healthy adults.
Sources for this answer
- Yorvipath 294 micrograms/0.98 mL solution for injection in pre filled penAscendis Pharma UK Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked